Nicolas Willand

Synthetic EthR inhibitors boost antituberculous activity of ethionamide

Nicolas Willand, Bertrand Dirié, Xavier Carette et al. · Nature Medicine · 2009 · 171 citations

Synthetic Ethr Inhibitors, Medicine, Pharmacotherapy +5

Reversion of antibiotic resistance in <i>Mycobacterium tuberculosis</i> by spiroisoxazoline SMARt-420

Nicolas Blondiaux, Martin Moune, Matthieu Desroses et al. · Science · 2017 · 140 citations · Full text

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles

Joana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny et al. · Scientific Reports · 2017 · 94 citations · Full text

Natural Compounds: Leads or Ideas? Bioinspired Molecules for Drug Discovery

Terence Beghyn, Rebecca Deprez‐Poulain, Nicolas Willand et al. · Chemical Biology & Drug Design · 2008 · 88 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biosynthesis +15

Ethionamide Boosters: Synthesis, Biological Activity, and Structure−Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors

Marion Flipo, Matthieu Desroses, Nathalie Lecat‐Guillet et al. · Journal of Medicinal Chemistry · 2011 · 84 citations · Full text

Drug Target, Pharmacotherapy, Chemical Biology +17